Valuation: Guizhou Bailing Group Pharmaceutical Co., Ltd.

Market Cap 606.06Cr 89Cr 78Cr 72Cr 67Cr 126.35Cr 8.51TCr 128.46Cr 861.6Cr 337.75Cr 4.18TCr 334.8Cr 327.56Cr 14TCr P/E 2024
193x
P/E 2025 -54.4x
Enterprise Value 693.53Cr 102.05Cr 89Cr 82Cr 76Cr 144.58Cr 9.74TCr 147Cr 985.94Cr 386.49Cr 4.78TCr 383.12Cr 374.84Cr 17TCr EV / Sales 2024
1.74x
EV / Sales 2025 2.23x
Free-Float
67.53%
Yield 2024 *
-
Yield 2025 -
1 day-0.89%
1 week-1.99%
Current month+2.30%
1 month-1.33%
3 months-11.73%
6 months+3.98%
Current year+2.07%
1 week 4.4
Extreme 4.4
4.74
1 month 4.21
Extreme 4.21
4.91
Current year 4.08
Extreme 4.08
5.47
1 year 4.08
Extreme 4.08
6.94
3 years 2.98
Extreme 2.98
8.8
5 years 2.98
Extreme 2.98
11.97
10 years 2.98
Extreme 2.98
25.83
Manager TitleAgeSince
Chief Executive Officer 56 02/04/2015
Director of Finance/CFO 41 29/12/2020
Corporate Officer/Principal 42 27/01/2014
Director TitleAgeSince
Chairman 56 27/03/2026
Director/Board Member 58 25/12/2007
Director/Board Member 42 27/01/2014
Date Insider Type Main position Quantity % Market Cap.
21/20/21Sell

Chairman

19,40,600 0.2495%
18/20/18Sell

Chairman

2,96,500 0.0381%
18/20/18Sell

Director

36,70,000 0.4719%
Change 5-day change 1-year change 3-year change Capi.($)
-0.89%-1.99%-18.23%-49.02% 89Cr
-0.64%-0.82%-13.70%-7.04% 1.27TCr
-1.20%-0.69%-35.00%-56.85% 466.59Cr
-0.40%-0.64%-8.24%-4.82% 439.51Cr
+0.55%+2.81%+23.16%-1.90% 391.84Cr
-1.24%-1.68%+2.64%-38.95% 373.44Cr
+1.30%+7.40%-7.31%-12.36% 326.85Cr
-0.14%+2.03%-11.48%+2.33% 308.65Cr
-0.89%+2.83%-5.79%-22.45% 242.24Cr
-0.50%+5.67%-6.00%+44.11% 180.57Cr
Average -0.41%+0.68%-7.99%-14.70% 408.86Cr
Weighted average by Cap. -0.44%+0.18%-9.13%-14.19%

Financials

2024 2025
Net sales 382.54Cr 56Cr 49Cr 45Cr 42Cr 80Cr 5.37TCr 81Cr 543.83Cr 213.18Cr 2.64TCr 211.32Cr 206.75Cr 9.14TCr 304.86Cr 45Cr 39Cr 36Cr 33Cr 64Cr 4.28TCr 65Cr 433.4Cr 169.89Cr 2.1TCr 168.41Cr 164.77Cr 7.28TCr
Net income 3.36Cr 49.48L 43.28L 39.91L 36.93L 70.09L 47Cr 71.26L 4.78Cr 1.87Cr 23Cr 1.86Cr 1.82Cr 80Cr -10Cr -1.54Cr -1.34Cr -1.24Cr -1.15Cr -2.18Cr -146.59Cr -2.21Cr -15Cr -5.82Cr -72Cr -5.77Cr -5.64Cr -249.35Cr
Net Debt 140.03Cr 21Cr 18Cr 17Cr 15Cr 29Cr 1.97TCr 30Cr 199.07Cr 78Cr 965.87Cr 77Cr 76Cr 3.35TCr 87Cr 13Cr 11Cr 10Cr 9.61Cr 18Cr 1.23TCr 19Cr 124.34Cr 49Cr 603.29Cr 48Cr 47Cr 2.09TCr
Logo Guizhou Bailing Group Pharmaceutical Co., Ltd.
Guizhou Bailing Group Pharmaceutical Co Ltd is a China-based company principally engaged in the research and development, production and sales of Miao medicine. The Company operates four segments. The Industrial segment is mainly engaged in the research and development, production and sales of Chinese patent medicine tablets, capsules and syrups. The Commercial segment is mainly engaged in drug distribution and big health business. The Medical Institution segment mainly operates diabetes hospitals. Other segment mainly provides Chinese medicinal materials and are engaged in organic fertilizer manufacturing, water production and supply and other businesses. The Company's products include Yindan Xinnaotong soft capsules, Kesuting syrup and capsules, Shuangyang Houbitong granules and non-Miao medicine products Jingan capsules, Vitamin C Yinqiao tablets, Xiaoer Chaigui antipyretic granules and other products. The Company mainly conducts its businesses in the domestic market.
Employees
5,715
Date Price Change Volume
09/26/09 CN¥4.440 -0.89% 63,69,203
08/26/08 CN¥4.480 +0.90% 55,99,400
07/26/07 CN¥4.440 -2.84% 71,32,200
06/26/06 CN¥4.570 -0.22% 1,21,14,522
03/26/03 CN¥4.580 +1.10% 1,33,19,700

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 002424 Stock